The Financial Times has named Oliver Barnes its U.S. deals and activist investor correspondent.
He has been covering U.S. biotechnology, pharmaceutical and health care companies.
Barnes has been the FT’s leisure industries correspondent based in London. He covers hospitality, gambling, tourism, tobacco and cannabis companies. He previously covered health and science for the FT. He was awarded a journalism prize by the Royal Statistical Society for his coverage of the pandemic.
Before joining the FT, he worked for BBC News, writing articles for Reality Check, the fact-checking arm of the BBC, and reporting for radio outlets including Radio 4 and the World Service.
He holds a bachelor’s degree from UCL and a master’s degree from City St. Georges, University of London.
